Verrica Pharmaceuticals (VRCA) PT Lowered to $13 at RBC Capital

August 15, 2024 6:16 AM

RBC Capital analyst Daniel Busby lowered the price target on Verrica Pharmaceuticals (NASDAQ: VRCA) to $13.00 (from $14.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found